MyPsoriasisTeam

Enbrel (Etanercept) is a biologic drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in adults and children over age 4, as well as psoriatic arthritis in adults. It works by attaching to tumor necrosis factor alpha (TNF-α), preventing it from signaling the immune system to attack Show Full Answer

Enbrel (Etanercept) is a biologic drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in adults and children over age 4, as well as psoriatic arthritis in adults. It works by attaching to tumor necrosis factor alpha (TNF-α), preventing it from signaling the immune system to attack connective tissues.

Key Points:
- Usage: Treats plaque psoriasis and psoriatic arthritis.
- Administration: Subcutaneous injection.
- Forms: Single-dose prefilled syringe and autoinjector.
- Common Side Effects: Infections, injection site reactions.
- Serious Side Effects: Increased risk of certain cancers, demyelinating diseases, congestive heart failure, anemia, serious allergic reactions.

For more detailed experiences, you might want to connect with others on platforms like MyPsoriasisTeam.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Enbrel (Etanercept) for Psoriasis | MyPsoriasisTeam

Enthesitis and Psoriatic Arthritis: Elbow Pain, Hip Pain, and More | MyPsoriasisTeam